Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma

IntroductionGemcitabine and cisplatin remain the cornerstone for the treatment of advanced or unresectable biliary tract cancers, but the incidence rate of the grade 3 or 4 toxic effects is high (70.7%). In recent years, significant progress has been achieved in the systemic treatment of cholangioca...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kang-shuai Li (Author), Yi Liu (Author), Tie-zhong Zhang (Author), Yun-fei Xu (Author), Zong-li Zhang (Author)
Format: Knjiga
Izdano: Frontiers Media S.A., 2024-11-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto